Skip to main content
Irl Hirsch, MD, Endocrinology, Seattle, WA

IrlBHirschMD

Endocrinology Seattle, WA

Diabetes, Lipid Metabolism

Professor of Medicine, University Wash

Dr. Hirsch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hirsch's full profile

Already have an account?

  • Office

    University Of Washington Diabetes Institue
    750 Republican, Building F, 3rd Floor
    Seattle, WA 98109
    Phone+1 206-616-6732

Summary

  • Dr. Irl Hirsch is an endocrinologist based in Seattle, WA, with subspecialties in diabetes and lipid metabolism. He completed his fellowship in endocrinology, diabetes, and metabolism at the Washington University/B-JH/SLCH Consortium after graduating from the University of Missouri-Columbia School of Medicine in 1984. Dr. Hirsch has served as a Professor of Medicine at the University of Washington School of Medicine since 1990. His expertise lies primarily in diabetes and hypoglycemia, and he has been involved in multiple clinical trials and published extensively in prominent journals. Notable publications include work in The Lancet, New England Journal of Medicine, JAMA, and Diabetes Care, focusing on diabetes research methodologies and treatment innovations. He has been recognized with awards such as America's Top Doctors by Castle Connolly.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1984

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1990 - 2026
  • FL State Medical License
    FL State Medical License 1985 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Women's Health Castle Connolly, 2008
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes  
    Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
  • Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020  
    Irl B Hirsch, Linda M Gaudiani, JAMA
  • Connecting the Dots: Validation of Time in Range Metrics with Microvascular Outcomes  
    Korey K Hood, Irl B Hirsch, Diabetes Care
  • Join now to see all

Lectures

  • Advances in Therapy 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/10/2019
  • 1st Annual Diabetes Symposium: New Advances and Innovations 
    Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012
  • Pregnancy Complicated by Diabetes and Severe Insulin Resistance (SIR): Review of 8 Cases on U-500 Regular Insulin (U500) 
    Seattle, WA - 6/15/2014

Authored Content

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
  • Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020May 2020

Press Mentions

  • What Did Your Breakfast Just Do to Your Blood Sugar? Continuous Glucose Monitoring Can ‘Empower’ the Diabetic and Non-Diabetic Alike, Experts Say
    What Did Your Breakfast Just Do to Your Blood Sugar? Continuous Glucose Monitoring Can ‘Empower’ the Diabetic and Non-Diabetic Alike, Experts SayJanuary 27th, 2025
  • Preventing DKA in Patients with T1D on SGLT2 Inhibitors
    Preventing DKA in Patients with T1D on SGLT2 InhibitorsDecember 23rd, 2024
  • Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DM
    Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DMDecember 17th, 2024
  • Join now to see all

Committees

  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2031
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
  • member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015

Professional Memberships